Metraipolis › archive › dc_0a839da372ef
Double-seronegative neuromyelitis optica: it is not possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638252
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41638252
- DOI
- 10.1055/s-[numero omesso]
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T20:41:51.881Z
- SHA-256 of the archived text
85033e09e8110f28cc706d30ebd9cc786895a52e677ad5038b9f0da294990ed6- Stable URL of this page
https://metraipolis.com/documento/dc_0a839da372ef
How to cite
Double-seronegative neuromyelitis optica: it is not possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638252 — Europe PMC (en), https://europepmc.org/article/MED/41638252 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0a839da372ef (Metraipolis archive dc_0a839da372ef, sha256 85033e09e8110f28cc706d30ebd9cc786895a52e677ad5038b9f0da294990ed6)
BibTeX
@misc{dc0a839da372ef,
title = {Double-seronegative neuromyelitis optica: it is not possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638252},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41638252},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0a839da372ef; sha256 85033e09e8110f28cc706d30ebd9cc786895a52e677ad5038b9f0da294990ed6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41638252. Agents can read the archived copy with the MCP tool read_document.